Accepted for Publication: July 21, 2013.
Published Online: October 14, 2013. doi:10.1001/jamainternmed.2013.10797.
Study concept and design: Walling, Tisnado, Malin, Dy, Lorenz.
Acquisition of data: Walling, Tisnado, Asch, Malin, Pantoja, Zisser, Schreibeis-Baum, Lorenz.
Analysis and interpretation of data: Walling, Tisnado, Pantoja, Dy, Ettner, Lee, Lorenz.
Drafting of the manuscript: Walling, Tisnado, Schreibeis-Baum, Lorenz.
Critical revision of the manuscript for important intellectual content: Walling, Tisnado, Asch, Malin, Pantoja, Dy, Ettner, Zisser, Lee, Lorenz.
Statistical Analysis: Walling, Tisnado, Pantoja, Ettner, Lee, Lorenz.
Obtained funding: Lorenz.
Administrative, technical, and material support: Walling, Tisnado, Asch, Pantoja, Schreibeis-Baum, Lorenz.
Study supervision: Walling, Tisnado, Dy, Zisser, Lorenz.
Conflict of Interest Disclosures: Dr Malin reported being employed by and having stock ownership with WellPoint. Dr Lorenz reported serving as a consultant to Otsuka Pharmaceuticals for data monitoring and safety in the evaluation of a phase II trial of Sativex, a novel cannabinoid analgesic. No other disclosures were reported.
Funding/Support: This study is based on work supported by the US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research & Development Service (project IIR 09-097).
Role of the Sponsors: The funding sources had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.
Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the US Department of Veterans Affairs or the US government.
Previous Presentation: The results of this study were presented at the American Society of Clinical Oncology Quality Symposium; December 1, 2012; San Diego, California.
Additional Contributions: We thank our medical record abstraction team, including Anna Dickey and Jennifer Larkin, for their contributions to the VA Cancer Quality–ASSIST national study.
Correction: This article was corrected online September 10, 2014, to fix a quality indicator statement in Table 3.